This indicates a more strongly activated TFEB/TFE3-driven transcriptional program in tRCC, potentially reflecting the increased transcriptional activity conferred by the oncofusion proteins compared to their wild-type counterparts. This evidence concerns the gene TFEB and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.